Ecuador vs Northern America: Proportion of the target population who received the final dose of
Ecuador
89.0%
in 2024
Northern America
55.0%
in 2024
Ecuador rank
11th
Northern America rank
9th
Proportion of the target population who received the final dose of over time
- Ecuador
- Northern America
How they compare
Ecuador currently reports 89.0% against 55.0% in Northern America, a difference of 34.0%.
That makes Ecuador's figure about 1.6 times Northern America's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was Ecuador ahead.
Ecuador ranks 11th and Northern America ranks 9th of 107 countries.
Across the 2 decades both report, Ecuador averaged higher in 1 and Northern America in 1.
Head to head by decade
| Decade | Ecuador | Northern America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.2% | 41.0% | 40.2% | Ecuador |
| 2020s | 45.8% | 53.8% | 8.0% | Northern America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Ecuador or Northern America?
- Ecuador, at 89.0% against 55.0% in Northern America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Ecuador and Northern America?
- 34.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Northern America?
- 11 years are reported by both, from 2014 to 2024.
- How do Ecuador and Northern America rank globally for proportion of the target population who received the final dose of?
- Ecuador ranks 11th and Northern America ranks 9th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.